Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue

被引:5
作者
Massey, Susan Christine [1 ]
Hawkins-Daarud, Andrea [1 ]
Gallaher, Jill [2 ]
Anderson, Alexander R. A. [2 ]
Canoll, Peter [3 ]
Swanson, Kristin R. [1 ]
机构
[1] Mayo Clin, Precis Neurotherapeut Innovat Program, 5777 E Mayo Blvd, Phoenix, AZ 85054 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Integrat Math Oncol, Tampa, FL USA
[3] Columbia Univ, Sch Med, Dept Pathol & Cell Biol, Div Neuropathol, New York, NY USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Platelet-derived growth factor; Scarring; Gliosis; Oligodendroglial progenitors; OLIGODENDROCYTE PRECURSOR CELLS; GROWTH-FACTOR EXPRESSION; FACTOR B-CHAIN; PROGENITOR CELLS; FIBROBLAST GROWTH; GLIAL PROGENITORS; WHITE-MATTER; RECEPTOR; PROLIFERATION; GLIOMAS;
D O I
10.1007/s11538-019-00587-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Paracrine PDGF signaling is involved in many processes in the body, both normal and pathological, including embryonic development, angiogenesis, and wound healing as well as liver fibrosis, atherosclerosis, and cancers. We explored this seemingly dual (normal and pathological) role of PDGF mathematically by modeling the release of PDGF in brain tissue and then varying the dynamics of this release. Resulting simulations show that by varying the dynamics of a PDGF source, our model predicts three possible outcomes for PDGF-driven cellular recruitment and lesion growth: (1) localized, short duration of growth, (2) localized, chronic growth, and (3) widespread chronic growth. Further, our model predicts that the type of response is much more sensitive to the duration of PDGF exposure than the maximum level of that exposure. This suggests that extended duration of paracrine PDGF signal during otherwise normal processes could potentially lead to lesions having a phenotype consistent with pathologic conditions.
引用
收藏
页码:1645 / 1664
页数:20
相关论文
共 64 条
  • [1] A single intracerebral microinjection of platelet-derived growth factor (PDGF) accelerates the rate of remyelination in vivo
    Allamargot, C
    Pouplard-Barthelaix, A
    Fressinaud, C
    [J]. BRAIN RESEARCH, 2001, 918 (1-2) : 28 - 39
  • [2] Role of platelet-derived growth factors in physiology and medicine
    Andrae, Johanna
    Gallini, Radiosa
    Betsholtz, Christer
    [J]. GENES & DEVELOPMENT, 2008, 22 (10) : 1276 - 1312
  • [3] ANDREW JG, 1995, BONE, V16, P455
  • [4] [Anonymous], 1968, HUMAN BRAIN FIGURES
  • [5] Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    Apperley, JF
    Gardembas, M
    Melo, JV
    Russell-Jones, R
    Bain, BJ
    Baxter, J
    Chase, A
    Chessells, JM
    Colombat, M
    Dearden, CE
    Dimitrijevic, S
    Mahon, FX
    Marin, D
    Nikolova, Z
    Olavarria, E
    Silberman, S
    Schultheis, B
    Cross, NCP
    Goldman, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 481 - 487
  • [6] Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses
    Assanah, Marcela
    Lochhead, Richard
    Ogden, Alfred
    Bruce, Jeffrey
    Goldman, James
    Canoll, Peter
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (25) : 6781 - 6790
  • [7] Assanah MC, 2009, GLIA
  • [8] Vascular insufficiency, not inflammation, contributes to chronic gliosis in a rat CNS transplantation model
    Bates, Kristyn A.
    Drummond, Eleanor S.
    Cozens, Greg S.
    Harvey, Alan R.
    [J]. RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2016, 34 (02) : 313 - 323
  • [9] Betsholtz Christer, 2003, Birth Defects Research, V69, P272, DOI 10.1002/bdrc.10030
  • [10] Bissell L, 2015, CURR STEM CELL RES T, V10, P19